AUSTRALIAN BERGAMET EXPERIENCE
BergaMet has been available in Australia since late 2010. I have now used this in around 600 patients, typically with great benefit & very rare, minor side effects. Our experience mirrors the Italian results with the majority of patients experiencing significant improvements in some & often all common cardiac risk factors.
Typically, there is around a 30% reduction in total cholesterol, somewhere between 35-40% reduction in LDL cholesterol & triglycerides, up to a 40% increase in HDL cholesterol, along with a 20-30% reduction in blood glucose levels & an associated improvement in HbA1C, the best indicator of long term diabetic control. There are also variable benefits in blood pressure control & weight loss, in particular reductions in abdominal obesity.
Also, independent of the above benefits we are witnessing profound reductions in arterial stiffness, an independent marker for cardiovascular risk. Since the introduction, a few months ago, of the more potent BergaMet Mega, the results have been even more impressive & consistent.
The evidence to date clearly supports the statement that Bergamet is the most powerful, natural agent for the management of lipid disorders.
It is my opinion that bergamet should be used in the following clinical scenarios
1) Low risk patients or in statin intolerant patients to lower cholesterol
2) In combination with statins to improve lipid values & minimise statin side effects
3) In all patients with Metabolic Syndrome, as it is the only monotherapy that affects every parameter of this increasingly common condition